Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mike Liang
AddedMar 31, 2024
UpdatedMay 31, 2026
Mike Liang

Mike Liang

Board Member, Illinois Ventures

Crunchbase

Mike Liang's Career

Illinois Ventures
Illinois Ventures

Chicago, IL, US

Board Member· Board
Amphora Medical
Amphora Medical

Maple Grove, MN, US

Board Member· Board
Zurex Pharma
Zurex Pharma

Middleton, WI, US

Board Member· Board
Insightra Medical
Insightra Medical

Irvine, CA, US

Board Member· Board
Apervita
Apervita

Chicago, IL, US

Board Member· Board
AiCure
AiCure

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mike Liang's Career

Illinois Ventures
Illinois Ventures
Investment FirmInvestment Firm112000Chicago, IL, US
Board Member· Board

Leadership at Illinois Ventures

Michael TokarzMichael TokarzBoard Member
Ed McMillanEd McMillanBoard Member
Avijit GhoshAvijit GhoshBoard Member
Nancy SullivanNancy SullivanCEO
Brendan FoxBrendan FoxBoard Member
Dave TolmieDave TolmieBoard Member
Amphora Medical
Amphora Medical
Series D$48.3M62011Maple Grove, MN, US
Board Member· Board

Leadership at Amphora Medical

Thomas ThalerThomas ThalerBoard Member
Chris OwensChris OwensBoard Member
Danny SachsDanny SachsFounder
Nicole J WalkerNicole J WalkerBoard Member
Thomas RessemannThomas RessemannCEO
Zurex Pharma
Zurex Pharma
Series A$38.7M352010Middleton, WI, US
Board Member· Board

Leadership at Zurex Pharma

Carmine DurhamCarmine DurhamCEO
Fred RobertsonFred RobertsonBoard Member
Robert B. TruittRobert B. TruittBoard Member
Mayumi Verona, BSN, RNMayumi Verona, BSN, RNBoard Member

Similar to Zurex Pharma

ZSX MedicalZSX MedicalPhiladelphia, PA, USMedical Devicesest. 2009ZSX MedicalPhiladelphia, PA, US · est. 2009

ZSX Medical, LLC: Innovating minimally-invasive surgery with Zip-stitch, a surgical closure system enhancing patient outcomes.

Series A · $3.7M11
ZocereZocereAlbuquerque, NM, USPharmaceuticalsest. 2012ZocereAlbuquerque, NM, US · est. 2012

Zocere: A seasoned team developing injectable drugs to combat neurological trauma since 2012.

Seed · $100k7
ZymeronZymeronDurham, NC, USHealthcareest. 2016ZymeronDurham, NC, US · est. 2016

Zymeron: A research-driven biotech firm innovating in healthcare tech for disease detection, prevention, and treatment.

Public · $75k13
ZylastZylastLake Forest, CA, USHealthcare Productsest. 2011ZylastLake Forest, CA, US · est. 2011

Innovative BioDefense, Inc.: Global provider of long-lasting antimicrobial healthcare products.

Seed · $350k50
Insightra Medical
Insightra Medical
Series A$20M232001Irvine, CA, US
Board Member· Board

Leadership at Insightra Medical

Brad SharpBrad SharpFounder
Apervita
Apervita
Series B$59.5M752012Chicago, IL, US
Board Member· Board

Leadership at Apervita

James P. BradleyJames P. BradleyBoard Member
Mark AchlerMark AchlerBoard Member
Adam KoopersmithAdam KoopersmithBoard Member
Paul MagelliPaul MagelliFounder
Kevin HutchinsonKevin HutchinsonCEO
AiCure
AiCure
Series A$68.8M842009New York City, NY, US
Board Member· Board

Leadership at AiCure

Adam HaninaAdam HaninaBoard Member
Laura ShafnerLaura ShafnerCo-Founder
Edward IkeguchiEdward IkeguchiCEO
Jeff AndersonJeff AndersonBoard Member
Gary VelasquezGary VelasquezBoard Member
Vijay LathiVijay LathiBoard Member

Similar to AiCure

PatientIQPatientIQChicago, IL, USHealthcare Analytics, Patient Engagementest. 2016PatientIQChicago, IL, US · est. 2016

PatientIQ offers cloud-based patient engagement tech, automating outcome collection and aiding recovery.

Series B · $26.2M73
CurebaseCurebaseSan Francisco, CA, USClinical Trials Softwareest. 2017CurebaseSan Francisco, CA, US · est. 2017

Curebase: Revolutionizing clinical trials with digital, accessible at-home research tools.

Series B · $57.5M175
CipherHealthCipherHealthNew York City, NY, USHealthcare Softwareest. 2009CipherHealthNew York City, NY, US · est. 2009

CipherHealth: A NY-based healthcare tech firm providing software solutions for enhanced patient care.

Series D · $55.5M151
HealthTalk A.I.HealthTalk A.I.Ashburn, VA, USPatient Engagementest. 2017HealthTalk A.I.Ashburn, VA, US · est. 2017

Health Talk A.I., a health tech company, excels in care coordination and artificial intelligence.

Seed · $370k9

Mike Liang's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Mike Liang

James S A MacdonaldJames S A MacdonaldBoard Member · Cormark SecuritiesAndrew MillerAndrew MillerBoard Member · iRobotMike RossMike RossBoard Member · Deciphera PharmaceuticalsMike MacalusoMike MacalusoCo-Founder · Ampio PharmaceuticalsGary GigotGary GigotBoard Member · VennliJim LiangJim LiangBoard Member · Vincere Biosciences